NURO — NeuroMetrix Balance Sheet
0.000.00%
- $8.94m
- -$4.16m
- $3.03m
- 20
- 42
- 82
- 46
Annual balance sheet for NeuroMetrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.23 | 22.6 | 21.2 | 18 | 13.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.334 | 0.311 | 0.647 | 0.519 | 0.193 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 7.09 | 24.2 | 24.1 | 20.9 | 15 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.876 | 0.674 | 0.536 | 0.544 | 0.311 |
Other Long Term Assets | |||||
Total Assets | 7.99 | 24.9 | 24.7 | 21.4 | 15.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 2.29 | 1.37 | 1.11 | 1.24 | 1.01 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.75 | 1.67 | 1.31 | 1.33 | 1.01 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.25 | 23.2 | 23.4 | 20.1 | 14.3 |
Total Liabilities & Shareholders' Equity | 7.99 | 24.9 | 24.7 | 21.4 | 15.3 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |